Europe Pharmaceutical Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Pharmaceutical market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Pharmaceutical Market Segmentations:

    By Player:

    • Daiichi Sankyo

    • Otsuka

    • GlaxoSmithKline

    • Bayer

    • Merck KGaA

    • Lilly

    • Biogen Idec

    • Roche

    • Bristol-Myers Squibb

    • Gilead Sciences

    • Boehringer Ingelheim

    • Baxter

    • Novartis

    • Takeda

    • AstraZeneca

    • AbbVie

    • Teva

    • Actavis

    • Amgen

    • Astellas

    • Sanofi

    • Pfizer

    • Novo Nordisk

    • Johnson & Johnson

    By Type:

    • Brand Medicine

    • Generic Medicine

    By End-User:

    • Hospitals & Clinics

    • Personals

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmaceutical Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Pharmaceutical Market Size and Growth Rate of Brand Medicine from 2014 to 2026

    • 1.3.2 Europe Pharmaceutical Market Size and Growth Rate of Generic Medicine from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Pharmaceutical Market Size and Growth Rate of Hospitals & Clinics from 2014 to 2026

    • 1.4.2 Europe Pharmaceutical Market Size and Growth Rate of Personals from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pharmaceutical Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmaceutical by Major Types

      • 3.4.1 Market Size and Growth Rate of Brand Medicine

      • 3.4.2 Market Size and Growth Rate of Generic Medicine

    4 Segmentation of Pharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmaceutical by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pharmaceutical for Hospitals & Clinics

      • 4.4.2 Market Size and Growth Rate of Pharmaceutical for Personals

    5 Market Analysis by Major Regions

    • 5.1 Europe Pharmaceutical Production Analysis by Top Regions

    • 5.2 Europe Pharmaceutical Consumption Analysis by Top Regions

    • 5.3 Europe Pharmaceutical Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.3 France Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Production, Import, Consumption and Export Analysis

    6 Product Circulation of Pharmaceutical Market among Top Countries

    • 6.1 Top 5 Export Countries in Pharmaceutical Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Pharmaceutical Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pharmaceutical Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pharmaceutical Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Pharmaceutical Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pharmaceutical Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Pharmaceutical Landscape Analysis

    • 7.1 Germany Pharmaceutical Landscape Analysis by Major Types

    • 7.2 Germany Pharmaceutical Landscape Analysis by Major End-Users

    8. UK Pharmaceutical Landscape Analysis

    • 8.1 UK Pharmaceutical Landscape Analysis by Major Types

    • 8.2 UK Pharmaceutical Landscape Analysis by Major End-Users

    9. France Pharmaceutical Landscape Analysis

    • 9.1 France Pharmaceutical Landscape Analysis by Major Types

    • 9.2 France Pharmaceutical Landscape Analysis by Major End-Users

    10. Italy Pharmaceutical Landscape Analysis

    • 10.1 Italy Pharmaceutical Landscape Analysis by Major Types

    • 10.2 Italy Pharmaceutical Landscape Analysis by Major End-Users

    11. Spain Pharmaceutical Landscape Analysis

    • 11.1 Spain Pharmaceutical Landscape Analysis by Major Types

    • 11.2 Spain Pharmaceutical Landscape Analysis by Major End-Users

    12. Poland Pharmaceutical Landscape Analysis

    • 12.1 Poland Pharmaceutical Landscape Analysis by Major Types

    • 12.2 Poland Pharmaceutical Landscape Analysis by Major End-Users

    13. Russia Pharmaceutical Landscape Analysis

    • 13.1 Russia Pharmaceutical Landscape Analysis by Major Types

    • 13.2 Russia Pharmaceutical Landscape Analysis by Major End-Users

    14. Switzerland Pharmaceutical Landscape Analysis

    • 14.1 Switzerland Pharmaceutical Landscape Analysis by Major Types

    • 14.2 Switzerland Pharmaceutical Landscape Analysis by Major End-Users

    15. Turkey Pharmaceutical Landscape Analysis

    • 15.1 Turkey Pharmaceutical Landscape Analysis by Major Types

    • 15.2 Turkey Pharmaceutical Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Landscape Analysis by Top Countries

      • 16.3.1 Denmark Pharmaceutical Market Volume and Growth Rate

      • 16.3.2 Finland Pharmaceutical Market Volume and Growth Rate

      • 16.3.3 Norway Pharmaceutical Market Volume and Growth Rate

      • 16.3.4 Sweden Pharmaceutical Market Volume and Growth Rate

      • 16.3.6 Iceland Pharmaceutical Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Landscape Analysis by Top Countries

      • 17.3.1 Belgium Pharmaceutical Market Volume and Growth Rate

      • 17.3.2 Netherlands Pharmaceutical Market Volume and Growth Rate

      • 17.3.3 Luxembourg Pharmaceutical Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Landscape Analysis by Top Countries

      • 18.3.1 Estonia Pharmaceutical Market Volume and Growth Rate

      • 18.3.2 Latvia Pharmaceutical Market Volume and Growth Rate

      • 18.3.3 Lithuania Pharmaceutical Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Daiichi Sankyo

      • 19.1.1 Daiichi Sankyo Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Otsuka

      • 19.2.1 Otsuka Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GlaxoSmithKline

      • 19.3.1 GlaxoSmithKline Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Bayer

      • 19.4.1 Bayer Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Merck KGaA

      • 19.5.1 Merck KGaA Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Lilly

      • 19.6.1 Lilly Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Biogen Idec

      • 19.7.1 Biogen Idec Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Roche

      • 19.8.1 Roche Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Bristol-Myers Squibb

      • 19.9.1 Bristol-Myers Squibb Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Gilead Sciences

      • 19.10.1 Gilead Sciences Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Boehringer Ingelheim

      • 19.11.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Baxter

      • 19.12.1 Baxter Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Novartis

      • 19.13.1 Novartis Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Takeda

      • 19.14.1 Takeda Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 AstraZeneca

      • 19.15.1 AstraZeneca Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 AbbVie

      • 19.16.1 AbbVie Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Teva

      • 19.17.1 Teva Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Actavis

      • 19.18.1 Actavis Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Amgen

      • 19.19.1 Amgen Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Astellas

      • 19.20.1 Astellas Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Sanofi

      • 19.21.1 Sanofi Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Pfizer

      • 19.22.1 Pfizer Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Novo Nordisk

      • 19.23.1 Novo Nordisk Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Johnson & Johnson

      • 19.24.1 Johnson & Johnson Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    The List of Tables and Figures (Totals 106 Figures and 160 Tables)

    • Figure Product Picture

    • Figure Europe Pharmaceutical Market Size and Growth Rate of Brand Medicine from 2014 to 2026

    • Figure Europe Pharmaceutical Market Size and Growth Rate of Generic Medicine from 2014 to 2026

    • Figure Europe Pharmaceutical Market Size and Growth Rate of Hospitals & Clinics from 2014 to 2026

    • Figure Europe Pharmaceutical Market Size and Growth Rate of Personals from 2014 to 2026

    • Figure Germany Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure France Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmaceutical by Different Types from 2014 to 2026

    • Table Consumption Share of Pharmaceutical by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Brand Medicine

    • Figure Market Size and Growth Rate of Generic Medicine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pharmaceutical by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pharmaceutical by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals & Clinics

    • Figure Market Size and Growth Rate of Personals

    • Table Europe Pharmaceutical Production by Major Regions

    • Table Europe Pharmaceutical Production Share by Major Regions

    • Figure Europe Pharmaceutical Production Share by Major Countries and Regions in 2014

    • Table Europe Pharmaceutical Consumption by Major Regions

    • Table Europe Pharmaceutical Consumption Share by Major Regions

    • Table Germany Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table UK Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table France Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Italy Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Spain Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Poland Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Russia Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Switzerland Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Turkey Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pharmaceutical Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Germany Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Germany Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Germany Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Consumption by Types from 2014 to 2026

    • Table UK Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table UK Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table France Pharmaceutical Consumption by Types from 2014 to 2026

    • Table France Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table France Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table France Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Italy Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Italy Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Spain Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Spain Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Poland Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Poland Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Russia Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Russia Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

    • Table Company Profile and Development Status of Otsuka

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka

    • Figure Sales and Growth Rate Analysis of Otsuka

    • Figure Revenue and Market Share Analysis of Otsuka

    • Table Product and Service Introduction of Otsuka

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Company Profile and Development Status of Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lilly

    • Figure Sales and Growth Rate Analysis of Lilly

    • Figure Revenue and Market Share Analysis of Lilly

    • Table Product and Service Introduction of Lilly

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Gilead Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences

    • Figure Sales and Growth Rate Analysis of Gilead Sciences

    • Figure Revenue and Market Share Analysis of Gilead Sciences

    • Table Product and Service Introduction of Gilead Sciences

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Actavis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

    • Figure Sales and Growth Rate Analysis of Actavis

    • Figure Revenue and Market Share Analysis of Actavis

    • Table Product and Service Introduction of Actavis

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.